Trandolapril and Verapamil Hydrochloride

NDC 68462-295 · Glenmark Pharmaceuticals Inc., USA

Generic nameTrandolapril and Verapamil Hydrochloride

Dosage formTABLET, FILM COATED, EXTENDED RELEASE

RouteORAL

Active ingredient(s)TRANDOLAPRIL, VERAPAMIL HYDROCHLORIDE

Strength2; 180 mg/1; mg/1

Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]

Marketing categoryANDA

Packages

68462-295-01 — 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-01)

68462-295-10 — 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-10)

68462-295-90 — 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68180-566 — Trandolapril, 68180-567 — Trandolapril, 68180-568 — Trandolapril, 68382-561 — Verapamil hydrochloride, 68382-562 — Verapamil hydrochloride, 68382-563 — Verapamil hydrochloride, 68462-260 — verapamil hydrochloride, 68462-292 — verapamil hydrochloride, 68462-293 — verapamil hydrochloride, 68462-294 — Trandolapril and Verapamil Hydrochloride, 68462-296 — Trandolapril and Verapamil Hydrochloride, 68462-329 — Trandolapril and Verapamil Hydrochloride, 68788-6328 — verapamil hydrochloride, 68788-8338 — VERAPAMIL HYDROCHLORIDE, 68788-8696 — VERAPAMIL HYDROCHLORIDE, 68788-9790 — Verapamil Hydrochloride, 70069-271 — Verapamil Hydrochloride, 70069-272 — Verapamil Hydrochloride, 70069-273 — Verapamil Hydrochloride, 70121-1585 — Verapamil Hydrochloride, +134 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels